PT839050E - Metodo de melhorar respostas imunes mediadas por celulas - Google Patents

Metodo de melhorar respostas imunes mediadas por celulas

Info

Publication number
PT839050E
PT839050E PT93921698T PT93921698T PT839050E PT 839050 E PT839050 E PT 839050E PT 93921698 T PT93921698 T PT 93921698T PT 93921698 T PT93921698 T PT 93921698T PT 839050 E PT839050 E PT 839050E
Authority
PT
Portugal
Prior art keywords
cells
immune responses
improving immune
immunogen
vaccinating
Prior art date
Application number
PT93921698T
Other languages
English (en)
Portuguese (pt)
Inventor
Baldir S Bhogal
Krishnaswamy I Dayalu
Jay D Gerber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT839050E publication Critical patent/PT839050E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
PT93921698T 1992-09-28 1993-09-21 Metodo de melhorar respostas imunes mediadas por celulas PT839050E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95224892A 1992-09-28 1992-09-28

Publications (1)

Publication Number Publication Date
PT839050E true PT839050E (pt) 2004-11-30

Family

ID=25492700

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93921698T PT839050E (pt) 1992-09-28 1993-09-21 Metodo de melhorar respostas imunes mediadas por celulas

Country Status (11)

Country Link
EP (1) EP0839050B1 (cg-RX-API-DMAC7.html)
JP (1) JPH08502253A (cg-RX-API-DMAC7.html)
AT (1) ATE273022T1 (cg-RX-API-DMAC7.html)
AU (1) AU687750B2 (cg-RX-API-DMAC7.html)
CA (1) CA2145760A1 (cg-RX-API-DMAC7.html)
DE (1) DE69333588T2 (cg-RX-API-DMAC7.html)
DK (1) DK0839050T3 (cg-RX-API-DMAC7.html)
ES (1) ES2225825T3 (cg-RX-API-DMAC7.html)
MX (1) MX9306016A (cg-RX-API-DMAC7.html)
PT (1) PT839050E (cg-RX-API-DMAC7.html)
WO (1) WO1994007531A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6620300A (en) 1999-08-03 2001-02-19 Ohio State University, The Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
IL159349A0 (en) 2001-07-02 2004-06-01 Pfizer Prod Inc One dose vaccination with mycoplasma hyopneumoniae
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
WO2006138675A2 (en) 2005-06-15 2006-12-28 The Ohio State University Research Foundation Her-2 peptides
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
EP2200643B1 (en) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
WO2011141443A1 (en) 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
DK0597852T4 (da) * 1990-05-29 2005-10-17 Wyeth Corp Svinepneumonivaccine og fremgangsmåde til fremstilling deraf
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof

Also Published As

Publication number Publication date
WO1994007531A1 (en) 1994-04-14
JPH08502253A (ja) 1996-03-12
AU4931293A (en) 1994-04-26
CA2145760A1 (en) 1994-04-14
DK0839050T3 (da) 2004-10-25
MX9306016A (es) 1995-01-31
AU687750B2 (en) 1998-03-05
EP0839050A1 (en) 1998-05-06
EP0839050A4 (cg-RX-API-DMAC7.html) 1998-05-06
DE69333588D1 (de) 2004-09-16
DE69333588T2 (de) 2005-08-04
ATE273022T1 (de) 2004-08-15
ES2225825T3 (es) 2005-03-16
EP0839050B1 (en) 2004-08-11

Similar Documents

Publication Publication Date Title
EP0438803A3 (en) Vaccines against cancer and infectious diseases
ES2059369T3 (es) Formulacion de vacuna.
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
DK0714444T3 (da) Dæmpning af en immundominant epitop i et antigen til anvendelse i plante-, dyre- og humanvacciner og immunbehandlinger
BR9106748A (pt) Vacina de hyopneumomiae micoplasma inativado e metodo de seu uso
ATE103180T1 (de) Impfstoff-zubereitung.
DK157087A (da) Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
PT839050E (pt) Metodo de melhorar respostas imunes mediadas por celulas
ID21338A (id) Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
DE2967036D1 (en) Vaccine and method of making
ES8207429A1 (es) Un procedimiento para la preparacion de un polisacarido antigenico.
JPS5726623A (en) Vaccine and manufacture
DK16087D0 (da) Mastitis-vaccine
EP0414816A4 (en) Induction of tolerance to a foreign antigen
EP0636030A4 (en) VACCINE AGAINST THE -I BACTERIAL OXIDE (PASTEURELLIA HAEMOLYTICA).
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
NZ212274A (en) Method of producing anti-male antibodies, antibodies so produced and lymphocytes
Ervucharakul et al. Experience in hepatitis B vaccination in general population.
CHEN et al. INVESTIGATION ON PRINCIPLE PARASITIC INFECTIONS IN THE SOUTHERN PART OF JIANGSU PROVINCE
YU et al. Comparision of immunogenicity of vaccine produced by different rabies the strain
Szemeredi et al. Guinea pig model experiment for testing the efficiency of leptospiral vaccine.
Zheng et al. Studies on the biological properties of a chemical vaccine prepared from antigenic fractions of Vibrio cholerae.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
ZA806606B (en) Specific antigen vaccine for tge in swine